A Study Evaluating Talazoparib (MDV3800) in Patients with Advanced Solid Tumors and a Normal or Decreased Liver Function

A Study Evaluating Talazoparib (MDV3800) in Patients with Advanced Solid Tumors and a Normal or Decreased Liver Function. A Phase 1 Open-Label Pharmacokinetics and Safety
Study of Talazoparib (MDV3800) in Patients With Advanced Solid Tumors and Normal or Varying Degrees of Hepatic Impairment.

Category & Conditions:
Cancer
Medicine:
TALZENNA™(TALAZOPARIB) CAPSULES
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
C3441002
Open Plain Language Summary Result:Click here